Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02549534 · ClinicalTrials.gov registry record
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 29
- Enrollment target
NCT02549534 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 29 participants.
The verdict
NCT02549534 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
Purpose: The purpose of the study is to test a new way of measuring nerve damage in women with breast cancer receiving chemotherapy drug paclitaxel (Taxol).
Interventions
- PROCEDURE Axon Reflexes
- PROCEDURE Axon Flares
- PROCEDURE Self-Reported Signs & Symptoms of CIPN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02549534
The ClinicalTrials.gov registry entry for NCT02549534 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Axon Reflexes is the first listed.
NCT02549534 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02549534 about?
NCT02549534 is a clinical study titled "Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer". Purpose: The purpose of the study is to test a new way of measuring nerve damage in women with breast cancer receiving chemotherapy drug paclitaxel (Taxol).
What is the current status of trial NCT02549534?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2015-09. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02549534?
The interventions under investigation include: Axon Reflexes (PROCEDURE), Axon Flares (PROCEDURE), Self-Reported Signs & Symptoms of CIPN (PROCEDURE).
Who is sponsoring clinical trial NCT02549534?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.